6-31672030-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021221.3(LY6G5B):āc.354G>Cā(p.Glu118Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021221.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LY6G5B | NM_021221.3 | c.354G>C | p.Glu118Asp | missense_variant | 3/3 | ENST00000375864.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LY6G5B | ENST00000375864.5 | c.354G>C | p.Glu118Asp | missense_variant | 3/3 | 1 | NM_021221.3 | P1 | |
LY6G5B | ENST00000409525.1 | c.189G>C | p.Glu63Asp | missense_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000689 AC: 17AN: 246640Hom.: 0 AF XY: 0.0000595 AC XY: 8AN XY: 134412
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460796Hom.: 0 Cov.: 31 AF XY: 0.0000757 AC XY: 55AN XY: 726712
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.354G>C (p.E118D) alteration is located in exon 3 (coding exon 3) of the LY6G5B gene. This alteration results from a G to C substitution at nucleotide position 354, causing the glutamic acid (E) at amino acid position 118 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at